Safety and Efficacy of NRT6003 in Patients With Unresectable Hepatocellular Carcinoma
Conditions: Unresectable Hepatocellular Carcinoma Interventions: Drug: NRT6003 Injection Sponsors: Chengdu New Radiomedicine Technology Co. LTD. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
Conditions: Urothelial Carcinoma Sponsors: Tampere University Hospital; Tampere University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
Conditions: Liver Cirrhosis; Hepatocellular Carcinoma Interventions: Procedure: Abdominal US; Procedure: AMRI Sponsors: So Yeon Kim Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Combination of SBRT and Immunotherapy in Small Hepatocellular Carcinoma (HSBRT2402)
Conditions: Hepatocellular Carcinoma Interventions: Radiation: Stereotactic body radiotherapy; Drug: Sintilimab Sponsors: Sun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Ningbo Medical Center Lihuili Eastern Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
De-escalated Radiotherapy for Primary Tumor After Neoadjuvant Therapy With Toripalimab Plus Chemotherapy for Nasopharyngeal Carcinoma
Conditions: Nasopharyngeal Carcinoma; Radiotherapy; Complications; IMMUNOTHERAPY Interventions: Radiation: de-escalated radiotherapy; Radiation: conventional radiotherapy Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Precision Adjuvant Therapy After Surgery for Hepatocellular Carcinoma
Conditions: HCC Interventions: Drug: PD-1 monoclonal antibody and lenvatinib; Drug: PD-1 monoclonal antibody Sponsors: Chen Xiaoping Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer
Conditions: Bladder Cancer Interventions: Radiation: radiation therapy Sponsors: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer: From a Multicenter Phase II Cohort to a Phase III Randomized Controlled Study
Conditions: Locally Advanced Rectal Carcinoma Interventions: Drug: Tislelizumab Sponsors: Beijing Friendship Hospital; Beijing Chao Yang Hospital; Peking University Cancer Hospital& Institute; CHINA-JAPEN FRIENDSHIP HOSPITAL; Peking Union Medical College Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Fudan University; Changhai Hospital; RenJi Hospital; Sir Run Run Shaw Hospital, affiliated with the Zhejiang University School of Medicine; Shandong Provincial Hospital; Zhongnan Hospital of Wuhan University& Second Clinical Hospital of Wuhan University; The First Affiliated Hospital of Zhengzhou...
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Development of a Neuronal Microscope
Conditions: Hepatic Carcinoma Interventions: Genetic: genetic model Sponsors: Fondazione IRCCS Ca ' Granda, Ospedale Maggiore Policlinico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Conditions: Head and Neck Squamous Cell Carcinoma Interventions: Drug: INCB081776; Drug: Pembrolizumab; Radiation: Palliative RT Sponsors: University of Wisconsin, Madison; National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Retrospective and Prospective Observational Study in Patients With Advanced Basal Cell Carcinoma
Conditions: Basal Cell Carcinoma Sponsors: Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Phase 2 Study of WGI-0301 in Combination With Sorafenib for Advanced HCC
Conditions: Advanced Hepatocellular Carcinoma (HCC) Interventions: Drug: WGI-0301 at MTD/RP2D dose IV infusion, QW; Drug: WGI-0301 at MTD/RP2D -1 dose IV infusion, QW; Drug: Sorafenib 400 mg PO, BID continuously; Drug: Sorafenib 400 mg PO, BID Sponsors: Zhejiang Haichang Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Carbonic Anhydrase IX Enzyme in Triple Negative Breast Carcinoma
Conditions: Triple Negative Breast Cancer; Carbonic Anhydrase IX Interventions: Diagnostic Test: Carbonic anhydrase staining levels Sponsors: Kahramanmaras Sutcu Imam University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Conditions: Locally Advanced Colorectal Carcinoma; Recurrent Colorectal Carcinoma; Stage III Colorectal Cancer AJCC v8 Interventions: Drug: Aminolevulinic Acid; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Fluorescence-Guided Surgery; Procedure: Magnetic Resonance Imaging; Drug: Photodynamic Therapy; Procedure: Surgical Procedure Sponsors: Roswell Park Cancer Institute; National Center for Advancing Translational Sciences (NCATS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 13, 2024 Category: Research Source Type: clinical trials
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Conditions: Castration-Resistant Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IVB Prostate Cancer AJCC v8 Interventions: Procedure: Biopsy; Procedure: Bone Scan; Procedure: Computed Tomography; Drug: Leuprolide Acetate; Procedure: Magnetic Resonance Imaging; Other: Survey Administration; Drug: Testosterone Cypionate Sponsors: Roswell Park Cancer Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
